Wiley acquires publications from Carpe Diem Communications

January 25, 2007

Hoboken, N.J., January 24, 2007--John Wiley & Sons, Inc. (NYSE:JWa) (NYSE:JWb), announced today that it has acquired three controlled-circulation publications from Carpe Diem Communications, Inc., of Yardley, Pennsylvania. The acquisition expands Wiley's global controlled-circulation portfolio of life and physical science offerings.

"These titles complement Wiley's collection of controlled-circulation publications in the life and physical sciences, particularly in the United States, where it expands our reach into dynamic and growing markets," said Vickie Thaw, Vice President and Publisher, John Wiley & Sons, Inc. "We welcome this opportunity to provide practical must-have information to researchers and professionals in the pharmaceutical and food industries."

The three periodicals are: Food Quality, PFQ (Pharmaceutical Formulation & Quality), and Contamination Control.

Food Quality (www.foodquality.com), which premiered in 1994, was the first magazine focused on food safety and quality in the United States. A leading publication for the food industry for over a decade, Food Quality is an American Society of Business Press Editors (ASBPE) award winner.

PFQ (Pharmaceutical Formulation & Quality) (www.pharmaquality.com), launched in 1997, covers trends and advances in product development, formulation, quality control, regulations, and drug delivery. With readers in North America and Europe, PFQ has developed into one of the leading magazines serving the drug development industry over the past decade. PFQ is another ASBPE award winning publication.

Launched in 2005, Contamination Control (www.contamination-control.com), focuses on the life science industry, covering the technology and methods used to prevent contamination in the manufacturing of pharmaceuticals, biopharmaceuticals, and medical devices.

Wiley has assumed publication of the three titles, which are available in print and online at no charge to qualified readers.

In addition to the publications, Wiley has also acquired the Carpe Diem name, which will now be known as a Carpe Diem - A Wiley Company. Rick Biros, Founder/President Carpe Diem Communications has joined Wiley as Publisher.

"Wiley's extensive global editorial, sales, marketing and technical expertise will allow the publications to continue to grow and provide our readers with the important information they depend on to keep up with the latest technology advancements and to make good business decisions," said Rick Biros, Founder/President, Carpe Diem Communications. "We recognize many cross-pollinization opportunities between Carpe Diem's publications and Wiley's journals in both print and new media. I look forward to working with the Carpe Diem - Wiley team on realizing the potential of this acquisition."
-end-
About Wiley

Founded in 1807, John Wiley & Sons, Inc., provides must-have content and services to customers worldwide. Its core businesses include scientific, technical, and medical journals, encyclopedias, books, and online products and services; professional and consumer books and subscription services; and educational materials for undergraduate and graduate students and lifelong learners. Wiley has publishing, marketing, and distribution centers in the United States, Canada, Europe, Asia, and Australia. The Company is listed on the New York Stock Exchange under the symbols JWa and JWb. Wiley's Internet site can be accessed at http://www.wiley.com.

Wiley

Related Pharmaceutical Articles from Brightsurf:

GARDP partners with Japanese pharmaceutical in pursuit of new antibiotics
The Global Antibiotic Research and Development Partnership (GARDP) has today announced an agreement with Daiichi Sankyo for GARDP to access and screen the Daiichi Sankyo chemical library.

The integrated catalysts can simplify pharmaceutical manufacturing
Prof. In Su Lee and his research team from POSTECH developed catalytic platforms based on metal organic frameworks.

Study: Pharmaceutical companies marketing stimulants to physicians
Results of a new study show that a large number of physicians in the US may have received marketing payments from pharmaceutical companies that produce stimulant medications.

3D printing with applications in the pharmaceutical industry
This achievement will have applications in the pharmaceutical industry, such as in the preparation of biocompatible biosensors based in gold, which have already been shown to be effective in the detection of carcinogenic cells and tumour biomarkers.

Turning wood into pharmaceutical ingredients 
Production of hazardous waste during drug manufacturing is a serious concern for the pharmaceutical industry.

New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.

Active pharmaceutical ingredients can persist in the environment
A study finds trace levels of medicines in drinking water from private wells.

Drug development stakeholders call for improved pharmaceutical testing
Published in Drug Discovery Today, 'Advancing Nonclinical Innovation and Safety in Pharmaceutical Testing' identifies the necessary steps that will lead to safer and more effective medicines, guided by a greater focus on human-based in vitro and in silico methods, which allow scientists to observe human cells, tissues, and biological processes, and their interaction with potential medications.

A step ahead in pharmaceutical research
Researchers of the University of W├╝rzburg have developed a method that makes it possible to measure the activation of receptors in a very short time.

Are pharmaceutical marketing payments to physicians for opioids associated with prescribing?
Pharmaceutical industry marketing of opioid products to physicians through nonresearch payments, which can include speaking fees and meals, was associated with greater opioid prescribing.

Read More: Pharmaceutical News and Pharmaceutical Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.